LNA-modified ASO complementary to the binding site of SMN-AS1 to PRC2 transfected to fibroblast from patients with SMA led to almost 6 fold increase in full-length SMN mRNA. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.